Black Titan (BTTC) vs Outlook Therapeutics (OTLK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Outlook Therapeutics is the larger company by market cap ($137.3 million vs $6.8 million), about 20.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTTC | OTLK |
|---|---|---|
| Share price | $0.495 | $0.564 |
| Market cap | $6.78M | $137.30M |
| 1-day change | -3.51% | -4.41% |
| YTD return | — | -64.30% |
| 1-year return | — | -55.24% |
| 5-year return | — | -98.66% |
| EPS (TTM) | $-0.46 | $-0.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.05 | $2.54 |
| 52-week low | $0.342 | $0.161 |
| Distance from 52-week high | -95.07% | -77.78% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +791.84% |
| Average volume | 11.84M | 13.33M |
| Shares outstanding | 13.70M | 243.45M |
| Employees | — | 17 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Outlook Therapeutics is about 20.2 times larger than Black Titan by market value ($137.30M vs $6.78M).
About Outlook Therapeutics
OTLK stock →Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 17 employees
BTTC vs OTLK FAQ
Which is bigger, Black Titan or Outlook Therapeutics?
Outlook Therapeutics (OTLK) is larger, with a market capitalization of $137.30M compared with $6.78M for Black Titan (BTTC).
Are Black Titan and Outlook Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.